Skip to main content

Advertisement

SpringerLink
Log in

Mucositis guidelines: what have they achieved, and where to from here?

  • Editorial
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rubenstein EB et al (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100(9 Suppl):2026–2046

    Article  PubMed  Google Scholar 

  2. Sonis ST et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9 Suppl):1995–2025

    Article  PubMed  Google Scholar 

  3. MASCC/ISOO, T.M.s.g.o. (2005) Summary of evidence-based clinical practice guidelines for care of patients with oral and gastrointestinal mucositis (2005 update). http://www.mascc.org

  4. Keefe DM, Peterson DE, Schubert MM (2006) Developing evidence-based guidelines for management of alimentary mucositis: process and pitfalls. Support Cancer Therapy (in press)

  5. Peterson D, Keefe D, Hutchins R, Schubert M (2005) Alimentary tract mucositis in cancer patients: impact of terminology and assessment on research and clinical practice. Support Care Cancer (in press)

  6. Jones J, Avritsher E, Cooksley C, Michelet M, Nebiyou Bekele B, Elting L (2005) Epidemiology of treatment associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. Support Care Cancer (in press)

  7. Anthony L, Bowen J, Garden A, Hewson I, Sonis S (2005) New thoughts on the pathobiology of regimen-related mucosal injury. Support Care Cancer (in press)

  8. von Bultzingslowen I, Brennan M, Spijkervet F, Logan R, Stringer A, Raber J, Keefe DM (2005) Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis. Support Care Cancer (in press)

  9. Altman A, Barasch A, Damato K, Elad S, Epstein J (2005) Antimicrobials, mucosal coating agents, anesthetics, analgesics and nutritional supplements in alimentary mucositis. Support Care Cancer (in press)

  10. Migliorati C, Oberle-Edwards L, Schubert M (2005) The role of alternative and natural agents, ice, and laser in the management of alimentary tract mucositis. Support Care Cancer (in press)

  11. McGuire D, Johnson J, Wienandts P, Correa E (2005) The role of basic oral care and good clinical practice principles in the management of oral mucositis. Support Care Cancer (in press)

  12. McGuire DB, Johnson J, Migliorati C (2005) Promulgation of guidelines for mucositis management: educating health care professionals and patients. Support Care Cancer (in press)

  13. Lalla R, Schubert M, Bensadoun R-J, Keefe D (2005) Anti-inflammatory agents in the management of alimentary mucositis. Support Care Cancer (in press)

  14. Bensadoun R-J, Schubert M, Lalla R, Keefe D (2005) Amifostine in the management of radiation-induced and chemotherapy-induced alimentary mucositis. Support Care Cancer (in press)

  15. Keefe D, Lees J, Horvath N (2005) Palifermin for oral mucositis: the Royal Adelaide Hospital experience. Support Care Cancer (in press)

  16. Brennan M, von Bultzingslowen I, Schubert M, Keefe D (2005) Alimentary mucositis: putting the guidelines into practice. Support Care Cancer (in press)

  17. Spielberger R et al (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers (see comment). N Engl J Med 351(25):2590–2598

    Article  PubMed  CAS  Google Scholar 

  18. Min D et al (2002) Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 99(12):4592–4600

    Article  PubMed  CAS  Google Scholar 

  19. Farrell CL et al (2002) The effects of keratinocyte growth factor in preclinical models of mucositis. Cell Prolif 35(Suppl 1):78–85

    Article  PubMed  CAS  Google Scholar 

  20. Gibson R, Keefe DM (2006) Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage, possible prevention strategies and treatment of the clinical problem. Support Care Cancer (in press)

  21. The Antiemetic Study Group of MASCC (2005) The 2004 Perugia international antiemetic conference. Support Care Cancer 13(2):77–133

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mucositis Study Group, MASCC/ISOO, Department of Medical Oncology, Royal Adelaide Hospital, North Terrace, Adelaide, 5000, Australia

    Dorothy M. K. Keefe

Authors
  1. Dorothy M. K. Keefe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dorothy M. K. Keefe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keefe, D.M.K. Mucositis guidelines: what have they achieved, and where to from here?. Support Care Cancer 14, 489–491 (2006). https://doi.org/10.1007/s00520-006-0056-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-006-0056-3

Keywords

Search

Navigation